COAG
Hemab Therapeutics Holdings, Inc.
Next earnings ≈ Aug 20, 2026 · est. from filing cadence
Last earnings -0.6% on 2026-05-21
$32.37
▲ +16.77%$32.37▲ +79.83%
over 1Y
L $18.00EODHDH $34.00
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+16.8%
1W+2.0%
1M+13.2%
3M+79.8%
YTD+79.8%
1Y+79.8%
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 9 analysts
Buy
Mixed signals in the latest filings.
Hemab Therapeutics Holdings, Inc. shows limited reported revenue.
Key statistics
Valuation
Enterprise value—
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield—
FCF yield—
Quality & risk
ROIC (est.)—
Free cash flow—
Total debt—
Net cash—
Capital returns
Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsSome governance/structural items recently, but no outright red flags.
Recent filings
all on EDGAR ↗4Period ending 2026-06-152026-06-17open ↗4Period ending 2026-05-192026-05-21open ↗10-QPeriod ending 2026-03-312026-05-21open ↗8-KPeriod ending 2026-05-212026-05-21open ↗4Period ending 2026-05-122026-05-14open ↗3Period ending 2026-05-042026-05-14open ↗SCHEDULE 13GFiling2026-05-11open ↗4Period ending 2026-05-072026-05-11open ↗SCHEDULE 13DFiling2026-05-11open ↗8-KPeriod ending 2026-05-082026-05-11open ↗SCHEDULE 13GFiling2026-05-08open ↗4Period ending 2026-05-042026-05-06open ↗
Frequently asked
- Is Hemab Therapeutics Holdings, Inc. (COAG) a buy?
- COAG currently carries a Sell rating with 2/5 conviction, derived from its latest SEC filings. Mixed signals in the latest filings.
Sources: SEC EDGAR (CIK 0002114044, latest 10-Q filed 2026-05-21) · EODHD · as of 6/28/2026, 3:41:16 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.